Research literacy
In Vitro vs. In Vivo: What Do Peptide Studies Actually Show?
In vitro studies examine biological processes outside an intact organism, such as in cells grown in a dish. In vivo studies examine them within a living organism. These terms tell you where an experiment happens; understanding what it measured tells you what the result means. Here, the examples focus on laboratory and non-human research.
What does in vitro mean?
In vitro describes experiments performed outside an intact organism. A peptide researcher might examine binding to an isolated receptor, a protein that receives a molecular signal. Another experiment might measure the response of cells grown in a dish. Both can be in vitro, even though one uses isolated components and the other uses living cells. [1] [3]
Living cells in a dish are still outside an intact organism. Even cells of human origin can be studied in vitro; their origin does not turn the experiment into a study in human participants. [3]
A simpler system can help researchers isolate a particular interaction. For example, a test of peptide–receptor binding can address whether those molecules interact under the test conditions. It cannot, by itself, describe everything that follows in an organism. [8]
What does in vivo mean?
In vivo describes a process studied within a living organism. In non-human peptide research, that organism might be a mouse, a fish or a plant. A laboratory setting does not make an experiment in vitro: a response taking place within an intact laboratory animal or growing seedling is in vivo. [2] [4] [5]
Within an organism, tissues interact and signals pass between them. Researchers can observe a response in that connected system, then use additional experiments to investigate the molecular steps behind it. [8]
The particular organism still matters. In animal papers, species, strain, sex, age and genetic background help define the model and can influence the findings. “Observed in mice” is useful context; the methods should identify which mice and under what conditions. [4]
Why a cell result can differ from an organism result
A peptide binding to a receptor and a cell responding to that binding are different events. Researchers need measurements suited to each question. A cell experiment also leaves out interactions with other tissues that may matter inside an organism. [8]
Even two cell experiments can differ. The cell type, its surroundings and the amount of a receptor it produces can affect the response being measured. These details help explain why a result in one system may not carry over to another. [3] [8]
The comparisons below are illustrative research questions, not findings about a particular peptide.
| Question | A suitable type of experiment | What remains unresolved |
|---|---|---|
| Does the peptide bind this receptor? | An in vitro binding experiment using the receptor. | Whether binding triggers a cellular response. |
| Does it change a signal inside cells? | An in vitro experiment measuring that signal in a defined cell model. | Whether the same response occurs in other cells or an intact organism. |
| Does a biological feature change in the organism? | An in vivo comparison that measures the feature of interest. | Which molecular steps explain the change, unless those steps are also tested. |
Does the peptide bind this receptor?
- A suitable type of experiment
- An in vitro binding experiment using the receptor.
- What remains unresolved
- Whether binding triggers a cellular response.
Does it change a signal inside cells?
- A suitable type of experiment
- An in vitro experiment measuring that signal in a defined cell model.
- What remains unresolved
- Whether the same response occurs in other cells or an intact organism.
Does a biological feature change in the organism?
- A suitable type of experiment
- An in vivo comparison that measures the feature of interest.
- What remains unresolved
- Which molecular steps explain the change, unless those steps are also tested.
One peptide study, two experimental settings
Plants use peptide signals too. Lee and colleagues studied epidermal patterning factor 2 (EPF2) and Stomagen in Arabidopsis thaliana, a small flowering plant. These peptides help regulate stomata, tiny pores on its surface. [5]
Isolated receptor experiments showed both peptides binding to ERECTA, a receptor protein. Competition tests with extracted membranes showed Stomagen displacing EPF2 from receptor binding. This examined interactions outside the intact plant. [5]
In living seedlings, EPF2 restricted stomatal development. Stomagen counteracted that restriction under the tested conditions. The seedling observations connected the molecular findings with development in a growing organism. [5]
The binding experiments helped explain how the peptides competed at the receptor. The seedling experiments showed a developmental response in the plant. Those are complementary findings about this system, not evidence that unrelated peptides behave the same way. [5]
Explore the original study and Figure 3
What to look for in Figure 3
Compare receptor competition in panel d with seedling images in panel f. What did each measure? A single figure can contain more than one experimental setting. [5]
Is in vivo evidence always stronger?
No. An isolated-receptor experiment may be well suited to a binding question, while a study of development needs a model that includes the relevant developmental process. Choose the evidence that matches the question, then examine how well the experiment was designed. [3] [5]
Study design matters in both settings. Appropriate comparison groups help researchers interpret a change. The Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines call for clear descriptions of the groups being compared and why those comparisons were chosen. The phrase “in vivo” supplies none of that information on its own. [6]
Neither label establishes safety or effectiveness in people. Both describe the setting of an experiment, not a conclusion that transfers automatically to a different species, peptide or product.
Where does ex vivo fit?
Ex vivo commonly describes experiments on tissue taken from an organism and studied outside it. That tissue may retain some of its original organization. The term overlaps with broad uses of in vitro, which can include experiments on isolated tissue. Read the methods to identify what was removed and what was measured, rather than treating the label as a separate level of proof. [7]
Keep the model in the conclusion
When you read a peptide claim, try finishing this sentence: “In [the model], the researchers measured [the outcome], compared with [the comparison group].” If the paper does not supply one of those details, leave it as an open question.
For an illustrative cell experiment, a careful summary might read: “In cultured cells, the researchers measured a larger signaling response in the peptide-exposed group than in the control group.” That sentence identifies the setting, measurement and comparison. “The peptide works” leaves all three unclear.
Before extending a finding to another setting, look for experiments that test that setting. The guide below offers a fuller checklist for reading the methods and judging whether the evidence supports the conclusion.
Use the research-paper guide to examine the methods and evidence →
References
- National Cancer Institute — Definition of in vitro
- National Cancer Institute — Definition of in vivo
- NC3Rs — DRIVER recommendations – Experimental model
- ARRIVE Guidelines — 8a. Experimental animals – Explanation
- Lee et al. (2015) — Competitive binding of antagonistic peptides fine-tunes stomatal patterning
- ARRIVE Guidelines — 1a. Study design – Explanation
- NC3Rs submission to POST: Technology alternatives to animals in life sciences research (September 2025)
- Sum et al. (2019), Assay Guidance Manual — Pharmacological Characterization of GPCR Agonists, Antagonists, Allosteric Modulators and Biased Ligands from HTS Hits to Lead Optimization